Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate-and high-grade lymphoma: International index high and high-intermediate risk group

Blood

Volumn 90, Issue 10, 1997, Pages 3844-3852

  Nademanee, Auayporn ^a   Molina, Arturo ^b   O'Donnell, Margaret R ^b   Dagis, Andrew ^b   Snyder, David S ^b   Parker, Pablo ^b   Stein, Anthony ^b   Smith, Eileen ^b   Planás, Ina ^b   Kashyap, Ashwin ^b   Spielberger, Ricardo ^b   Fung, Henry ^b   Wong, K K ^b   Somlo, George ^b   Margolin, Kim ^b   Chow, Warren ^b   Sniecinski, Irena ^b   Vora, Nayana ^b   Blume, Karl G ^b   Niland, Joyce ^b   Forman, Stephen J ^b   more..

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; LACTATE DEHYDROGENASE;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER STAGING; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; HUMAN; LYMPHOMA; MALE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RISK FACTOR; STEM CELL TRANSPLANTATION; SURVIVAL RATE; VEIN OCCLUSION;

EID: 0030730567     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.10.3844     Document Type: Article

References (36)

1. Coiffier B, Lepage E: Prognosis of aggressive lymphoma: A study of five prognostic models with patients included in the LNH-84 regimen. Blood 74:558, 1989
2. Shipp MA: Prognostic factors in aggressive non-Hodgkin's lymphoma: Who has "high-risk" disease? Blood 83:1165, 1994
3. Shipp MA, et al: A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329:987, 1993
4. Bernstein JI, Coleman N, Strickler JG, Dorfman RF, Rosenberg SA: Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types). J Clin Oncol 4:847, 1986
5. Straus DJ, Wong GY, Liu J, Oppenberg J, Filippa DA, Gold JWM, Offit K, Clarkson BD: Small non-cleaved-cell lymphoma (undifferented lymphoma, Burkitt's type) in American adults: Results with treatment designed for acute lymphoblastic leukemia. Am J Med 90:328, 1991
6. Kirn D, Mauch P, Shaffer K, Pinkus G, Shipp MA, Kaplan WD, Tung N, Wheeler C, Beard CJ, Canellos GP, Shulman LN: Large-cell and immunoblastic lymphoma of the mediastinum: Prognostic features and treatment outcome in 57 patients. J Clin Oncol 11:1336, 1993
7. Nademanee AP, Schmidt GM, O'Donnell MR, Snyder DS, Parker PA, Stein A, Smith E, Lipsett JA, Sniecinski I, Margolin K, Somlo G, Niland JC, Blume KG, Forman SJ: High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: A pilot study. Blood 80:1130, 1992
8. Kessinger A, Schmit-Pokorny K, Smith D, Armitage J: Cryopreservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transplant 5:25, 1990
9. O'Donnell MR, Schmidt GM, Tegtmeier BR, Faucett C, Fahey JL, Ito J, Nademanee A, Niland JC, Parker P, Smith E, Snyder DS, Stein AS, Blume KG, Forman SJ: Prediction of systemic fungal infection in allogeneic marrow recepients: Impact of amphotericin prophylaxis in high-risk patients. J Clin Oncol 12:827, 1994
10. McKelvey EM, Gottlieb JA, Wilson HE, Haut A, Talley RW, Stephens R, Lane M, Gamble JF, Jones SE, Grozea PN, Gutterman J, Coltman CC, Moon TE: Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer 38:1484, 1976
11. Gordon LI, Harrington D, Andersen J, Colgan J, Glick J, Neiman R, Mann R, Resnick GD, Barcos M, Goyylieb A, O'Connell M: Comparison of a second-generation combination chemotherpeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Engl J Med 327:1342, 1992
12. Fisher RI, Gaynor ER, Dahlberg S, Oken M, Grogan TM, Mize EM, Click JH, Coltman CA, Miller TP: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328:1002, 1993
13. Haioun C, Lepage E, Gisselbrecht c, Bastion Y, Coiffier B, Brice P, Bosly A, Dupriez B, Nouvel C, Tilly H, Lederlin P, Biron P, Gaulard P, Reyes F, for the Groupe d'Etude des Lymphomes de l'Adulte: Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2. J Clin Oncol 15:1131, 1997
14. Gulati SC, Shank B, Black P, Yapp J, Koziner B, Straus D, Filippa D, Kempin S, Castro-Malaspina H, Cunningham I, Berman E, Coleman M, Langleban A, Calvin O, Fuks Z, O'Reilly R, Clarkson B: Autologous bone marrow transplantation for patients with poor-prognosis lymphomas. J Clin Oncol 6:1303, 1988
15. Baro J, Richard C, Calavia J, Gonzalez-San Miquel JD, Bello-Fernandez C, Alsar MJ, Gomez-Casares MT, Iriondo A, Conde E, Hermosa V, Garijo J, Zubizarreta A: Autologous bone marrow transplantation as consolidation therapy for non-Hodgkin's lymphoma patients with poor prognostic features. Bone Marrow Transplant 8:283, 1991
16. Freedman AS, Takvorian T, Neuberg D, Mauch P, Rabinowe SN, Anderson KC, Soiffer RJ, Spector N, Grossbard M, Robertson MJ, Blake K, Coral F, Canellos GP, Ritz J, Nadler LM: Autologous bone marrow transplantation in poor-prognosis intermediate and high-grade B-cell non-Hodgkin's lymphoma in first remission: A pilot study. J Clin Oncol 931:936, 1993
17. Brugger W, Gramatzki M, Mertelsmann R, Kanz L: Early high-dose chemotherapy with autologous peripheral blood progenitor cell transplantation (PBPC-T) in patients with high-risk aggressive non-Hodgkin's lymphoma. Proc Am Soc Clin Oncol 14:327, 1995
18. Pettengell R, Radford JA, Morgenstern GR, Scarffe JH, Harris M, Woll PJ, Deakin DP, Ryder D, Wilkinson PM, Crowther D: Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma. J Clin Oncol 14:586, 1996
19. Verdonck LF, Van Putten WLJ, Hagenbeek A, Scheuten HC, Sonneveld P, Van Imhoff GW, Kluin-Nelemans HC, Raemaekers JMM, Van Oers RHJ, Haak HL, Schots R, Dekker AW, de Gast GC, Lowenberg B: Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med 332:1045, 1995
20. Martelli M, Vignetti M, Zinzani PL, Gherlinzoni F, Meloni G, Fiacchini M, De Sanctis V, Papa G, Martelli MF, Calabresi F, Tura S, Mandelli F: High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytararabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: A prospective randomized Italian multicenter study. J Clin Oncol 14:534, 1996
21. Gianni AM, Bregni M, Siena S, Brambilla C, Di Nicola M, Lombardi F, Gondola L, Tarella C, Pileri A, Stern A, Valagussa P, Bonadonna G: 5-Year update of the Milan Cancer Institute randomized trial of high-dose sequential (HDS) vs. MACOP-B therapy for diffuse large-cell lymphomas. Proc Am Soc Clin Oncol 13:373, 1994
22. Gianni AM, Bregni M, Siena S, Brambilla C, Nicola MD, Lombardi F, Gandola L, Tarella C, Pileri A, Ravagnani F, Valagussa P, Bonadonna G: High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 336:1290, 1997
23. Gisselbrecht C, Lepage E, Morel P, Lederlin P, Coiffier B, Tilly H, Bosly A, Gabarre J, Briere J, Fillet G, Molina T, Reves F: Intensified induction phase including autologous peripheral stem cell transplantation does not improve response rate and survival in lymphoma with at least two adverse prognostic factors when compared to ACVB regimen. Blood 88:120a, 1997 (abstr, suppl 1)
24. Todeschini G, Ambrosetti A, Meneghini V, Pizzolo G, Menestrina F, Chilosi M, Benedetti F, Veneri D, Cetto GL, Perona G: Mediastinal large B-cell lymphoma with sclerosis: A clinical study of 21 patients. J Clin Oncol 8:804, 1990
25. Falini B, Venturi S, Martelli M, Santucci A, Pileri S, Pescarmona E, Giovannini M, Mazza P, Martelli MF, Pasqualucci L, Ballatori E, Guglielmi C, Amadori S, Poggi S, Sabattini E, Gherlinzoni F, Zinzani PL, Baroni CD, Mandelli F, Tura S: Mediastinal large B-cell lymphoma: Clinical and immunohistological findings in 18 patients treated with different third-generation regimens. Br J Haematol 89:780, 1995
26. Kaplan WD, Jochelson MS, Herman TS, Nadler LM, Stomper PC, Takvorian T, Andersen JW, Canellos GP: Gallium-67 imaging: A predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma. J Clin Oncol 8:1966, 1990
27. McMaster ML, Greer JP, Greco FA, Johnson DH, Wolff SN, Hainsworth JD: Effective treatment of small noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapy. J Clin Oncol 9:941, 1991
28. Waits TM, Greco FA, Greer JP, Johnson DH, Wolff SN, Stein RS, McMaster ML, Hainsworth JD: Effective therapy for poor-prognostic non-Hodgkin's lymphoma with 8 weeks of high-dose intensity combination chemotherapy. J Clin Oncol 11:943, 1993
29. Longo DL, Duffey PL, Jaffe ES, Raffeld M, Hubbard SM, Fisher RI, Wittes RE, DeVita VT Jr, Young RC: Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: A high-grade lymphoma responsive to proMACE-based combination chemotherapy. J Clin Oncol 12:2153, 1994
30. Soussain C, Patte C, Ostronoff M, Delmer A, Rigal-Huguet F, Cambier N, Leprisé PY, Francois S, Cony-Makhoul P, Harousseau JL: Small noncleaved cell lymphoma in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood 85:664, 1995
31. Magrath I, Adde M, Shad A, Venzon D, Seibel N, Gootenberg J, Neely J, Arndt C, Nieder M, Jaffe E, Wittes R, Horak I: Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 14:925, 1996
32. Sweetenham JW, Pearce R, Taghipour G, Biaise D, Gisselbrecht C, Goldstone AH, for the European Group for Blood and Marrow Transplantation Lymphoma Working Party: Adults Burkitt's and Burkitt's like non-Hodgkin's lymphoma-outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: Results from the European Group for Blood and Marrow Transplantation. J Clin Oncol 14:2465, 1996
33. Traweek TS, Slovak ML, Nademanee AP, Brynes RK, Niland JC, Forman SJ: Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma. Blood 84:957, 1994
34. Stone RM, Neuberg D, Soiffer R, Takvorian T, Whelan M, Rabinowe SN, Aster JC, Leavitt P, Mauch P, Freedman AS, Nadler LM: Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 12:2535, 1994
35. Darrington DL, Vose JM, Anderson JR, Bierman PJ, Bishop MR, Chan WC, Morris ME, Reed EC, Sanger WG, Tarantolo SR, Weisenburger DD, Kessinger A, Armitage JO: Incidence and characterization of secondary myelodysplastic syndrome and acute myelogeneous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol 12:2527, 1994
36. Shipp MA, Neuberg D, Janicek M, Canellos GP, Shulman LN: High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: A dose-finding pilot study. J Clin Oncol 13:2916, 1995